233 related articles for article (PubMed ID: 30165365)
1. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
2. miRFA: an automated pipeline for microRNA functional analysis with correlation support from TCGA and TCPA expression data in pancreatic cancer.
Borgmästars E; de Weerd HA; Lubovac-Pilav Z; Sund M
BMC Bioinformatics; 2019 Jul; 20(1):393. PubMed ID: 31311505
[TBL] [Abstract][Full Text] [Related]
3. Clinically relevant circulating microRNA profiling studies in pancreatic cancer using meta-analysis.
Pei Z; Liu SM; Huang JT; Zhang X; Yan D; Xia Q; Ji C; Chen W; Zhang X; Xu J; Wang J
Oncotarget; 2017 Apr; 8(14):22616-22624. PubMed ID: 28186984
[TBL] [Abstract][Full Text] [Related]
4. A Machine Learning Method for a Blood Diagnostic Model of Pancreatic Cancer Based on microRNA Signatures.
Huang B; Xin C; Yan H; Yu Z
Crit Rev Immunol; 2024; 44(3):13-23. PubMed ID: 38421702
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of microRNAs in pancreatic cancer: a meta-analysis.
Zhao F; Wei C; Cui MY; Xia QQ; Wang SB; Zhang Y
Aging (Albany NY); 2020 May; 12(10):9380-9404. PubMed ID: 32420903
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA-422a is associated with lymphatic metastasis in lung cancer.
Wu L; Hu B; Zhao B; Liu Y; Yang Y; Zhang L; Chen J
Oncotarget; 2017 Jun; 8(26):42173-42188. PubMed ID: 28178679
[TBL] [Abstract][Full Text] [Related]
7. Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1).
Song H; Wang Q; Guo Y; Liu S; Song R; Gao X; Dai L; Li B; Zhang D; Cheng J
BMC Infect Dis; 2013 Jun; 13():257. PubMed ID: 23731466
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression in osteoarthritis: a meta-analysis.
Liu H; Yan L; Li X; Li D; Wang G; Shen NN; Li JJ; Wang B
Clin Exp Med; 2023 Nov; 23(7):3737-3749. PubMed ID: 37027064
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential microRNA panels for pancreatic cancer diagnosis using microarray datasets and bioinformatics methods.
Shams R; Saberi S; Zali M; Sadeghi A; Ghafouri-Fard S; Aghdaei HA
Sci Rep; 2020 May; 10(1):7559. PubMed ID: 32371926
[TBL] [Abstract][Full Text] [Related]
10. High expression levels of miR-21 and miR-210 predict unfavorable survival in breast cancer: a systemic review and meta-analysis.
Tang Y; Zhou X; Ji J; Chen L; Cao J; Luo J; Zhang S
Int J Biol Markers; 2015 Nov; 30(4):e347-58. PubMed ID: 26349663
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of plasma microRNAs for non-small cell lung cancer based on data mining models.
Yan M; Kang W; Liu X; Yang B; Sun N; Yang Y; Wang W
BMC Cancer; 2024 Jan; 24(1):52. PubMed ID: 38200421
[TBL] [Abstract][Full Text] [Related]
12. Exploring diagnostic and prognostic predictive values of microRNAs for acute myocardial infarction: A PRISMA-compliant systematic review and meta-analysis.
Lee GK; Hsieh YP; Hsu SW; Lan SJ
Medicine (Baltimore); 2021 Jul; 100(29):e26627. PubMed ID: 34398018
[TBL] [Abstract][Full Text] [Related]
13. Prognostic microRNAs as biomarkers for prostate cancer.
Palanisamy H; Manoharan JP; Vidyalakshmi S
J Cancer Res Ther; 2024 Jan; 20(1):297-303. PubMed ID: 38554337
[TBL] [Abstract][Full Text] [Related]
14. The biological functions of target genes in pan-cancers and cell lines were predicted by miR-375 microarray data from GEO database and bioinformatics.
Zeng JH; Liang XZ; Lan HH; Zhu X; Liang XY
PLoS One; 2018; 13(10):e0206689. PubMed ID: 30379973
[TBL] [Abstract][Full Text] [Related]
15. Construction of a Nine-MicroRNA-Based Signature to Predict the Overall Survival of Esophageal Cancer Patients.
Zhang X; He Y; Gu H; Liu Z; Li B; Yang Y; Hao J; Hua R
Front Genet; 2021; 12():670405. PubMed ID: 34093662
[TBL] [Abstract][Full Text] [Related]
16. High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer.
Yi M; Liao Z; Deng L; Xu L; Tan Y; Liu K; Chen Z; Zhang Y
Ann Med; 2021 Dec; 53(1):2178-2193. PubMed ID: 34913774
[TBL] [Abstract][Full Text] [Related]
17. The microRNAs as prognostic biomarkers for survival in esophageal cancer: a meta-analysis.
Fu W; Pang L; Chen Y; Yang L; Zhu J; Wei Y
ScientificWorldJournal; 2014; 2014():523979. PubMed ID: 25097879
[TBL] [Abstract][Full Text] [Related]
18. Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer.
Shi W; Wartmann T; Accuffi S; Al-Madhi S; Perrakis A; Kahlert C; Link A; Venerito M; Keitel-Anselmino V; Bruns C; Croner RS; Zhao Y; Kahlert UD
Br J Cancer; 2024 Jan; 130(1):125-134. PubMed ID: 37950093
[TBL] [Abstract][Full Text] [Related]
19. The value of a panel of circulating microRNAs in screening prostate cancer.
Sun C; Lu C; Li X; Li R; Wen Z; Ge Z; Chen W; Li Y; Sun S; Yang Q; Tao L; Li H; Lai Y
Transl Cancer Res; 2024 Feb; 13(2):686-698. PubMed ID: 38482417
[TBL] [Abstract][Full Text] [Related]
20. A novel six-microRNA-based model to improve prognosis prediction of breast cancer.
Lai J; Wang H; Pan Z; Su F
Aging (Albany NY); 2019 Jan; 11(2):649-662. PubMed ID: 30696800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
